Please login to the form below

Not currently logged in
Email:
Password:
PMLiVE Top Pharma List

3

Revenue 2017

Roche

The Top Pharma List rankings are compiled from GlobalData's pharmaceutical revenue figures, which are based on prescription medicine sales, including generics drugs. They have been compiled below into an infographic of Roche's 2013 sales performance.

Roche

Roche’s Spinraza, Zolgensma rival risdiplam hits the mark in SMA

Roche’s Spinraza, Zolgensma rival risdiplam hits the mark in SMA

Roche’s hopes of capturing a slice of the spinal muscular atrophy market have been buoyed by phase 3 data showing its risdiplam drug can improve motor function in patients with ... Roche is also emphasising the safety of risdiplam, saying that “no

HTA guidance from NICE, the SMC and the AWMSG

process. sales. Not-so-lucky was Roche’s Perjeta (pertuzumab),. 3 Oct 2019. One of NICE’s concerns was that there was no direct comparison between weekly taxanes such as paclitaxel

Teva names new CFO and bulks up its opioid liability fund

Teva names new CFO and bulks up its opioid liability fund One bright spot for the company this week was the US launch of Celltrion-partnered Truxima – the first biosimilar of Roche’s big-selling Rituxan (rituximab) to reach the US market –

Targacept picks Solvay's Stephen Hill to fill vacant CEO post

Targacept picks Solvay's Stephen Hill to fill vacant CEO post Prior to that, he served at US biotech ArQule and Roche, where he held several leadership positions including global head of clinical development.

Biogen takes on Lucentis, Eylea biosimilars from Samsung joint venture

Biogen takes on Lucentis, Eylea biosimilars from Samsung joint venture Under the deal, Biogen is taking exclusive rights to Samsung Bioepis’ SB11, a biosimilar of Novartis/Roche’s Lucentis (ranibizumab), as well as SB15 which is a version of ... Meanwhile, off-label use of Roche’s VEGF inhibitor Avastin (bevacizumab)

1 2 3 4 5 6 7 8 9 10 [ Next 5 results ]

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Frontera Group

Welcome to Frontera Group where our agencies immerse you in the world of the patient...

Latest intelligence

APAC map
Pharmaceutical innovation in the APAC region
A first-of-its-kind study paints a vivid picture of the APAC region’s future...
Patient journey mapping: exploring the clinical and the emotional journey
By Chris Hodgson, Neil Rees, Sumira Riaz and Karen Petticrew While we can all agree that the value of developing a patient journey map cannot be underestimated when exploring the...
Precision medicine at Blue Latitude Health
At Blue Latitude Health we have identified 90+ insights about commercialising precision medicines. Check out our video to get a run down on three core components of the commercialisation and...

Infographics